Search Results - "pharmacometrics"

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development by Rami Ayoun Alsoud, Robin J. Svensson, Elin M. Svensson, Elin M. Svensson, Stephen H. Gillespie, Martin J. Boeree, Andreas H. Diacon, Rodney Dawson, Rodney Dawson, Rob E. Aarnoutse, Ulrika S. H. Simonsson

Connect to this object online.

Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients by Laura Galeotti, Francesco Ceccherini, Carmen Fucile, Valeria Marini, Antonello Di Paolo, Natalia Maximova, Francesca Mattioli

Connect to this object online.

A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes by Curtis K. Johnston, Rena J. Eudy-Byrne, Ahmed Elmokadem, Valerie Nock, Jan Marquard, Nima Soleymanlou, Matthew M. Riggs, Karl-Heinz Liesenfeld

Connect to this object online.

Steering Away from Current Amoxicillin Dose Reductions in Hospitalized Patients with Impaired Kidney Function to Avoid Subtherapeutic Drug Exposure by Cornelis Smit, Swapnoleena Sen, Elodie von Dach, Abderrahim Karmime, Pierre Lescuyer, David Tonoli, Julia Bielicki, Angela Huttner, Marc Pfister

Connect to this object online.

Tapering of biological treatment in autoinflammatory diseases: a scoping review by Tatjana Welzel, Lea Oefelein, Marinka Twilt, Marc Pfister, Jasmin B. Kuemmerle-Deschner, Susanne M. Benseler

Connect to this object online.

Integration of individual preclinical and clinical anti‐infective PKPD data to predict clinical study outcomes by Vincent Aranzana‐Climent, Wisse van Os, Amir Nutman, Jonathan Lellouche, Yael Dishon‐Benattar, Nadya Rakovitsky, George L. Daikos, Anna Skiada, Ioannis Pavleas, Emanuele Durante‐Mangoni, Ursula Theuretzbacher, Mical Paul, Yehuda Carmeli, Lena E. Friberg

Connect to this object online.

Asia‐inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler by Hong Lu, Lena Klopp‐Schulze, Jatinder Kaur Mukker, Dandan Li, Yoshihiro Kuroki, Jayaprakasam Bolleddula, Nadia Terranova, Kosalaram Goteti, Wei Gao, Rainer Strotmann, Jennifer Dong, Karthik Venkatakrishnan

Connect to this object online.

Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study by Orestis Papasouliotis, David Mitchell, Pascal Girard, Fernando Dangond, Martin Dyroff

Connect to this object online.

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model by M G Vossen, S Pferschy, C Milacek, M Haidinger, Mario Karolyi, Zoltan Vass, Heinz Burgmann, Alexandra Maier-Salamon, S G Wicha, W Jäger, M Zeitlinger, T Stimpfl, T Wittek, F Thalhammer

Connect to this object online.

Comparison of Compartmental and Non-Compartmental Analysis to Detect Biopharmaceutical Similarity of Intravenous Nanomaterial-Based Rifabutin Formulations by Nadezhda Osipova, Andrey Budko, Olga Maksimenko, Elena Shipulo, Ludmila Vanchugova, Wenqian Chen, Svetlana Gelperina, Matthias G. Wacker

Connect to this object online.